an experimental experience

12/1/23 at 9:10pm

Organization

Author

40 words

Comments

Pfizer said Friday it would not advance development of a twice-daily oral weight-loss drug because of its side effects. PFE stock fell.

You are the first to view

https://www.investors.com/news/technology/pfe-stock-slides-after-pfizers-latest-setback-for-weight-loss-drug/

Create an account or login to join the discussion